A recent WebMD article discussed a nationwide thyroid drug recall linked to incorrect information on the label. The drug in question is Acella Pharmaceuticals’ NP Thyroid medication intended to treat hypothyroidism. During routine testing, the affected lots were found to contain less than 90% of the two ingredients listed on the label: liothyronine and levothyroxine.
Incorrect Label Potency Leads to Thyroid Drug Recall
Acella Pharmaceuticals has recalled its thyroid medication for the third time in a year over potency issues.
May 14, 2021
Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
